James Wilbur

Chief Commercial Officer, 10X Genomics.

Companies

10X GenomicsChief Commercial Officer Aug 3, 2022 to Nov 27, 2023¹

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

10X Genomics TXG83,342 shares²$5.8M at $69.95Nov 22, 2023

As of each latest filing. The line shows shares held over time.

Recent filings

Nov 22, 2023Sold 3,464 shares at $43.34 of 10X Genomics²
Nov 20, 2023Sold 14,718 shares at $42.09 of 10X Genomics³
Aug 22, 2023Sold 9,699 shares at $45.78 of 10X Genomics⁴
May 23, 2023Sold 316 shares at $55.07 of 10X Genomics⁵
Mar 21, 2023Granted 14,555 shares of 10X Genomics⁶
Sep 14, 2022Granted 95,839 shares of 10X Genomics⁷

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGAR10X Genomics, Chief Commercial Officer
2
SEC EDGAR10X Genomics shares after the filing of Nov 22, 2023
3
SEC EDGARForm 4 filed Nov 22, 2023
4
SEC EDGARForm 4 filed Aug 24, 2023
5
SEC EDGARForm 4 filed May 25, 2023
6
SEC EDGARForm 4 filed Mar 23, 2023
7
SEC EDGARForm 4 filed Sep 16, 2022